DHA (omega-3) optimal range and reference range

Compiled by Alina Radu, founder of Sera, from the published sources below · Last reviewed November 9, 2026

Sera's bands for DHA (omega-3):

  • Optimal 3 – 8 %; sufficient 2 – 10 %; out of range below 2 or above 10 %.

Evidence grade: Functional / longevity target. A narrower target in common use in functional, integrative, preventive and longevity practice. It is not a universally validated diagnostic range.

At Sera's last range review a change to this band was proposed and held, because the evidence for it was thin, so the band is unchanged. The note below says where it matches published intervals and where it does not.

All units

UnitOptimalSufficientOut of range
%3 – 82 – 10below 2 or above 10

What the evidence says

DHA-specific outcome thresholds are less established than for the Omega-3 Index; the bands reflect functional targets and population distributions rather than a validated cut-off. Slower to shift than EPA, so a low value reflects a longer-standing pattern rather than the last few weeks. No reference interval or guideline threshold exists for red cell DHA as a percentage. In the Framingham cohort the highest fifth, above about 6%, had fewer cardiovascular events and lower mortality than the lowest fifth, below about 3.7%; the optimal band here starts at 3%, inside that lowest fifth.

Assay: Results differ meaningfully between platforms and methods. Compare against the interval printed by the issuing laboratory before acting on a borderline value.

Sources

What DHA (C22:6 n-3, RBC) measures

Docosahexaenoic acid. A long-chain omega-3 fatty acid concentrated in brain and retinal tissue, measured as a share of red blood cell membrane fatty acids.

The structural omega-3: it makes up a large share of the fat in neural membranes, which is why intake matters in pregnancy and through later life. Slower to move than EPA, so a low value reflects a longer-standing pattern.

Related fatty acids markers

See DHA (omega-3) in the full list of biomarker ranges

About the author

Alina Radu is the founder of Sera and a software engineer. The idea started with her own Hashimoto's tests, scattered across years without the big picture. She is not a clinician: these ranges are compiled from the published sources linked on each page, with every source named. Alina Radu on LinkedIn

This page is a reference for practitioners, not medical advice. Sera's bands are practitioner targets for structured review, not diagnostic thresholds, and Sera does not diagnose or recommend treatment. Read a result alongside the interval printed by the issuing laboratory and the client's history and symptoms. Range set: Sera Production, version 1.0, last reviewed November 9, 2026.